申请人:FORUM Pharmaceuticals Inc.
公开号:US20170066753A1
公开(公告)日:2017-03-09
The present disclosure relates to oxadiazine compounds, pharmaceutical compositions comprising an effective amount of an oxadiazine compound and methods for using an oxadiazine compound in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of an oxadiazine compound.